NCT05382286 · Interventional trial
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
Overall registry status Active not recruiting
Phase 3
Conditions PD-L1 Positive, Triple Negative Breast Cancer
Delaware Valley sites
- Rutgers Cancer Institute of New Jersey,2575 Klockner Road · Hamilton, NJ · Mercer County
- University of Pennsylvania Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory